Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-4

  Qayyum, Tahir ^a   McArdle, Peter ^b   Orange, Clare ^c   Seywright, Morag ^c   Horgan, Paul ^a   Oades, Grenville ^b   Aitchison, Michael ^b   Edwards, Joanne ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

Fuhrman grade; Renal cell cancer

Indexed keywords

EID: 84887264775     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-378     Document Type: Article

References (23)

1. Al-Aynati M, Chen V, Salama S, Shuhaibar H, Treleaven D, Vincic L (2003) Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch Pathol Lab Med 127:593-596.
2. Arner O, Blanck C, Von ST (1965) Renal adenocarcinoma; morphology-grading of malignancy-prognosis. A study of 197 cases. Acta Chir Scand Suppl 346:1-51.
3. Bektas S, Bahadir B, Kandemir NO, Barut F, Gul AE, Ozdamar SO (2009) Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma. Kaohsiung J Med Sci 25:596-600.
4. Bostwick DG, Murphy GP (1998) Diagnosis and prognosis of renal cell carcinoma: highlights from an international consensus workshop. Semin Urol Oncol 16:46-52.
5. Delahunt B (1998) Histopathologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol 15:68-76.
6. Delahunt B, Nacey JN (1987) Renal cell carcinoma. II. Histological indicators of prognosis. Pathology 19:258-263.
7. Ficarra V, Righetti R, Martignoni G, D'Amico A, Pilloni S, Rubilotta E, Malossini G, Mobilio G (2001) Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int 67:130-134.
8. Ficarra V, Martignoni G, Maffei N, Brunelli M, Novara G, Zanolla L, Pea M, Artibani W (2005) Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 103:68-75.
9. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168:2395-2400.
10. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663.
11. Hong SK, Jeong CW, Park JH, Kim HS, Kwak C, Choe G, Kim HH, Lee SE (2011) Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma. BJU Int 107:409-415.
12. Lang H, Lindner V, de Fromont Molinie V, Letourneux H, Meyer N, Martin M, Jacqmin D (2005) Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up. Cancer 10:625-629.
13. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H (2003) Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97:1663-1671.
14. Lohse CM, Blute ML, Zincke H, Weaver AL, Cheville JC (2002) Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am J Clin Pathol 118:877-886.
15. Medeiros LJ, Gelb AB, Weiss LM (1988) Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases. Cancer 61:1639-1651.
16. Medeiros LJ, Jones EC, Aizawa S, Aldape HC, Cheville JC, Goldstein NS, Lubensky IA, Ro J, Shanks J, Pacelli A, Jung SH (1997) Grading of renal cell carcinoma: Workgroup No. 2. Union Internationale Contre le Cancer and the American Joint Committee on Cancer (AJCC). Cancer 80:990-991.
17. Patard JJ, Leray E, Rodriguez A, Rioux-Leclercq N, Guille F, Lobel B (2003) Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol 44:226-232.
18. Rioux-Leclercq N, Karakiewicz PI, Trinh QD, Ficarra V, Cindolo L, de la Taille A, Tostain J, Zigeuner R, Mejean A, Patard JJ (2007) Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer 109:868-874.
19. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF (1971) Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 28:1165-1177.
20. Sun M, Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Pharand D, Latour M, Perrotte P, Patard JJ, Karakiewicz PI (2009) A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Eur Urol 56:775-781.
21. Syrjanen K, Hjelt L (1978) Grading of human renal adenocarcinoma. Scand J Urol Nephrol 12:49-55.
22. Thoenes W, Storkel S, Rumpelt HJ (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181:125-143 www.cancerresearchuk.org.
23. Zisman A, Pantuck AJ, Dorey F, Said JW, Shvarts O, Quintana D, Gitlitz BJ, Dekernion JB, Figlin RA, Belldegrun AS (2001) Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19:1649-1657.